Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $1.15 Million - $1.5 Million
29,162 New
29,162 $1.19 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $4.16 Million - $4.94 Million
-89,486 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $4.09 Million - $5.07 Million
89,486 New
89,486 $4.63 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $1.55 Million - $2.3 Million
-37,525 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $934,228 - $1.2 Million
23,802 Added 173.45%
37,525 $1.61 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $1.89 Million - $2.14 Million
-52,583 Reduced 79.3%
13,723 $537,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $2.22 Million - $2.5 Million
66,306 New
66,306 $2.4 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $2.84 Million - $3.33 Million
-89,372 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $2.27 Million - $2.75 Million
75,237 Added 532.27%
89,372 $2.92 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $195,264 - $278,990
7,224 Added 104.53%
14,135 $461,000
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $2.44 Million - $2.77 Million
-74,148 Reduced 91.47%
6,911 $270,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $2.63 Million - $3.42 Million
81,059 New
81,059 $2.91 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $1.9 Million - $2.21 Million
-59,646 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $731,952 - $776,627
22,007 Added 58.47%
59,646 $2.16 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $1.17 Million - $1.29 Million
37,639
37,639 $1.34 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.